0001179110-20-003834.txt : 20200317 0001179110-20-003834.hdr.sgml : 20200317 20200317172238 ACCESSION NUMBER: 0001179110-20-003834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200313 FILED AS OF DATE: 20200317 DATE AS OF CHANGE: 20200317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rizvi Qasim CENTRAL INDEX KEY: 0001794636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 20722093 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS CORP. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 edgar.xml FORM 4 - X0306 4 2020-03-13 0 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001794636 Rizvi Qasim CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA 0 1 0 0 Chief Commercial Officer Share Option 15.52 2020-03-13 4 A 0 75000 0 A 2030-03-12 Class A Common Shares 75000 75000 D The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is March 13, 2020. /s/ Thomas W. Beetham, Attorney-in-Fact For Qasim Rizvi 2020-03-17